Zymeworks Inc ZYME:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 04/18/24 EDT
8.67quote price arrow down-0.18 (-2.03%)
Volume
381,476
52 week range
6.01 - 13.14
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close8.67
  • 52 Week High13.14
  • 52 Week High Date02/27/24
  • 52 Week Low6.01
  • 52 Week Low Date10/04/23

Key Stats

  • Market Cap611.826M
  • Shares Out70.57M
  • 10 Day Average Volume0.52M
  • Dividend-
  • Dividend Yield-
  • Beta1.14
  • YTD % Change-16.55

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close8.67
  • 52 Week High13.14
  • 52 Week High Date02/27/24
  • 52 Week Low6.01
  • 52 Week Low Date10/04/23
  • Market Cap611.826M
  • Shares Out70.57M
  • 10 Day Average Volume0.52M
  • Dividend-
  • Dividend Yield-
  • Beta1.14
  • YTD % Change-16.55

RATIOS/PROFITABILITY

  • EPS (TTM)-1.73
  • P/E (TTM)-5.01
  • Fwd P/E (NTM)-10.45
  • EBITDA (TTM)-127.889M
  • ROE (TTM)-24.78%
  • Revenue (TTM)76.012M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-156.13%
  • Debt To Equity (MRQ)0.03%

EVENTS

  • Earnings Date05/02/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Zymeworks Inc

 

Profile

MORE
Zymeworks Inc. is a global biotechnology company. The Company is engaged in the discovery, development, and commercialization of multifunctional biotherapeutics to treat cancer and other serious diseases. Its complementary therapeutic platforms and fully integrated drug development engine provide the flexibility and compatibility to precisely engineer and develop differentiated antibody-based therapeutic candidates. Its platforms include Azymetric, Drug Conjugate Platforms...
Kenneth Galbraith
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer
Address
108 Patriot Drive, Suite A
Middletown, DE
19709
United States

Top Peers

SYMBOLLASTCHG%CHG
EXAI
Exscientia PLC
4.36+0.04+0.93%
CVAC
CureVac NV
2.44-0.13-5.06%
VERV
Verve Therapeutics Inc
6.66-0.08-1.19%
STOK
Stoke Therapeutics Inc
11.65-0.07-0.60%
ANAB
AnaptysBio Inc
19.83-1.64-7.64%